SUBSCRIBE
SUBSCRIBE

Indications

PRESS RELEASES
Press Releases
Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma
October 1, 2026
 · 
8 min read
Press Releases
Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference
October 1, 2026
 · 
3 min read
Press Releases
U.S. Food and Drug Administration Approves Expanded Indication for Bristol Myers Squibb’s CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) in Adults and Pediatric Patients*
October 1, 2026
 · 
19 min read
Press Releases
Meitheal Pharmaceuticals Announces FDA Approval of High-Concentration Formulation of YUSIMRY®, a Biosimilar to Humira®
September 28, 2026
 · 
14 min read
Press Releases
Galderma and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for NEMLUVIO® (nemolizumab), for moderate-to-severe atopic dermatitis and prurigo nodularis
September 28, 2026
 · 
9 min read
Press Releases
U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related to Breast Cancer
September 28, 2026
 · 
9 min read
Press Releases
4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
September 28, 2026
 · 
9 min read
Press Releases
Jaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy
September 28, 2026
 · 
10 min read
Press Releases
Croma-Pharma Introduces saypha® volume prime Lidocaine
September 25, 2026
 · 
3 min read
Press Releases
Nanexa and Novo enter into EUR 1.165 billion global license and collaboration agreement for long-acting injectables
September 25, 2026
 · 
3 min read
Press Releases
Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Approved in Japan for Subcutaneous Administration for All KEYTRUDA® (pembrolizumab) Indications Approved in Japan
September 21, 2026
 · 
19 min read
Press Releases
IntraBio Announces U.S. FDA Approval of AQNEURSA® (levacetylleucine) for Ataxia-Telangiectasia
September 21, 2026
 · 
9 min read
Press Releases
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis
September 18, 2026
 · 
9 min read
Press Releases
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN
September 17, 2026
 · 
15 min read
Press Releases
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
September 15, 2026
 · 
7 min read
Press Releases
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
September 15, 2026
 · 
5 min read
Press Releases
Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months
September 9, 2026
 · 
9 min read
Press Releases
Thryv Therapeutics Licenses a New Class of SGK1 Inhibitors from Spain’s CSIC and Universidad Autónoma de Madrid, Extending Its Platform into Neurodegenerative Disease
September 3, 2026
 · 
4 min read
Press Releases
HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy
September 3, 2026
 · 
11 min read
Press Releases
United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis
September 2, 2026
 · 
10 min read